Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection
- PMID:12853316
- DOI: 10.1111/j.1749-6632.2003.tb07532.x
Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection
Abstract
Poly(ADP-ribose) polymerase-1 (PARP-1) is an abundant nuclear enzyme that is activated primarily by DNA damage. Upon activation, the enzyme hydrolyzes NAD(+) to nicotinamide and transfers ADP ribose units to a variety of nuclear proteins, including histones and PARP-1 itself. This process is important in facilitating DNA repair. However, excessive activation of PARP-1 can lead to significant decrements in NAD(+), and ATP depletion, and cell death (suicide hypothesis). In response to cellular damage by oxygen radicals or excitotoxicity, a rapid and strong activation of PARP-1 occurs in neurons. Excessive PARP-1 activation is implicated in a variety of insults, including cerebral and cardiac ischemia, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism, traumatic spinal cord injury, and streptozotocin-induced diabetes. The use of PARP inhibitors has, therefore, been proposed as a protective therapy in decreasing excitotoxic neuronal cell death, as well as ischemic and other tissue damage. Excitotoxic brain lesions initially result in the primary destruction of brain parenchyma and subsequently in secondary damage of neighboring neurons hours after the insult. This secondary damage of initially surviving neurons accounts for most of the volume of the infarcted area and the loss of brain function after a stroke. One major component of secondary neuronal damage is the migration of macrophages and microglial cells toward the sites of injury, where they produce large quantities of toxic cytokines and oxygen radicals. Recent evidence indicates that this microglial migration is strongly controlled in living brain tissue by expression of the integrin CD11a, which is regulated in turn by PARP-1, proposing that PARP-1 downregulation may, therefore, be a promising strategy in protecting neurons from this secondary damage, as well. Studies demonstrating an important role for PARP-1 in the regulation of gene transcription have further increased the intricacy of poly(ADP-ribosyl)ation in the control of cell homeostasis and challenge the notion that energy collapse is the sole mechanism by which poly(ADP-ribose) formation contributes to cell death. The hypothesis that PARPs might regulate cell fate as essential modulators of death and survival transcriptional programs is discussed with relation to nuclear factor kappaB and p53.
Similar articles
- Poly(ADP-ribosyl)ation enzyme-1 as a target for neuroprotection in acute central nervous system injury.Skaper SD.Skaper SD.Curr Drug Targets CNS Neurol Disord. 2003 Oct;2(5):279-91. doi: 10.2174/1568007033482733.Curr Drug Targets CNS Neurol Disord. 2003.PMID:14529360Review.
- Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.Henning RJ, Bourgeois M, Harbison RD.Henning RJ, et al.Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2.Cardiovasc Toxicol. 2018.PMID:29968072Review.
- Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited.Chiarugi A.Chiarugi A.Trends Pharmacol Sci. 2002 Mar;23(3):122-9. doi: 10.1016/S0165-6147(00)01902-7.Trends Pharmacol Sci. 2002.PMID:11879679Review.
- Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA.Endres M, et al.J Cereb Blood Flow Metab. 1997 Nov;17(11):1143-51. doi: 10.1097/00004647-199711000-00002.J Cereb Blood Flow Metab. 1997.PMID:9390645
- The role of poly(ADP-ribose) polymerase-1 in CNS disease.Kauppinen TM, Swanson RA.Kauppinen TM, et al.Neuroscience. 2007 Apr 14;145(4):1267-72. doi: 10.1016/j.neuroscience.2006.09.034. Epub 2006 Nov 2.Neuroscience. 2007.PMID:17084037Review.
Cited by
- Ouabain induces apoptotic cell death in type I spiral ganglion neurons, but not type II neurons.Lang H, Schulte BA, Schmiedt RA.Lang H, et al.J Assoc Res Otolaryngol. 2005 Mar;6(1):63-74. doi: 10.1007/s10162-004-5021-6. Epub 2005 Apr 22.J Assoc Res Otolaryngol. 2005.PMID:15735933Free PMC article.
- Overview on poly(ADP-ribose) immuno-biomedicine and future prospects.Kanai Y.Kanai Y.Proc Jpn Acad Ser B Phys Biol Sci. 2016;92(7):222-36. doi: 10.2183/pjab.92.222.Proc Jpn Acad Ser B Phys Biol Sci. 2016.PMID:27477457Free PMC article.Review.
- The early activation of PI3K strongly enhances the resistance of cortical neurons to hypoxic injury via the activation of downstream targets of the PI3K pathway and the normalization of the levels of PARP activity, ATP, and NAD⁺.Noh MY, Kim YS, Lee KY, Lee YJ, Kim SH, Yu HJ, Koh SH.Noh MY, et al.Mol Neurobiol. 2013 Apr;47(2):757-69. doi: 10.1007/s12035-012-8382-6. Epub 2012 Dec 20.Mol Neurobiol. 2013.PMID:23254998
- Neuroprotection: lessons from hibernators.Dave KR, Christian SL, Perez-Pinzon MA, Drew KL.Dave KR, et al.Comp Biochem Physiol B Biochem Mol Biol. 2012 May;162(1-3):1-9. doi: 10.1016/j.cbpb.2012.01.008. Epub 2012 Feb 3.Comp Biochem Physiol B Biochem Mol Biol. 2012.PMID:22326449Free PMC article.Review.
- Role of nicotinamide in DNA damage, mutagenesis, and DNA repair.Surjana D, Halliday GM, Damian DL.Surjana D, et al.J Nucleic Acids. 2010 Jul 25;2010:157591. doi: 10.4061/2010/157591.J Nucleic Acids. 2010.PMID:20725615Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous